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Summary 
Interleukin (IL)-11 is a multifunctional cytokine whose role in osteoclast development has not 
been fully elucidated. We examined IL-11 production by primary osteoblasts and the effects of 
rat monoclonal anti-mouse glycoprotein 130 (gp130) antibody on osteoclast formation, using a 
coculture of mouse osteoblasts and bone marrow cells.  IL-1, TNFoL,  PGE2, parathyroid hor- 
mone (PTH)  and 1cl,25-dihydroxyvitamin D3  (leq25(OH)2D3)  similarly induced production 
of IL-11 by osteoblasts, but IL-6, IL-4, and TGF[3 did not. Primary osteoblasts constitutively 
expressed mRNAs for both IL-11 receptor (IL-11Ro  0  and gp130. Osteotropic factors did not 
modulate IL-11Ro~ mRNA at 24 h, but steady-state gp130  mRNA expression in osteoblasts 
was upregulated by 1ot,25(OH)2D 3, PTH, or IL-1. In cocultures, the formation ofmultinucle- 
ated osteoclast-like cells (OCLs) in response to IL-11, or IL-6 together with its soluble IL-6 re- 
ceptor was dose-dependently inhibited  by rat monoclonal anti-mouse gp130  antibody.  Fur- 
thermore, adding anti-gp130 antibody abolished OCL formation induced by IL-1, and partially 
inhibited OCL formation induced by PGE2, PTH, or 1oL,25(OH)2D3.  During osteoclast for- 
mation in marrow cultures, a sequential relationship existed between the expression of calcito- 
nin receptor mRNA and IL-11Ro~ mRNA. Osteoblasts as well as OCLs expressed transcripts 
for IL-11Rc~, as indicated by RT-PCR  analysis and in situ hybridization. These results suggest 
a central role of gp130-coupled cytokines, especially IL-11, in osteoclast development. Since 
osteoblasts and mature osteoclasts expressed IL-11Rct mRNA, both bone-forming and bone- 
resorbing cells are potential targets of IL-11. 
I 
nterleukin  (IL)-11 is a functionally pleiotropic cytokine 
that was  isolated from a  bone marrow-derived stromal 
cell line based on its ability to stimulate the proliferation of 
IL-6-dependent  cells  (1). An  indication  that  IL-11  might 
regulate connective tissue responses was given by its expres- 
sion  in  relatively restricted  cells  of the  mesenchymal lin- 
eage,  such  as  lung fibroblasts,  bone  marrow stromal cells, 
placental stromal cells,  articular chondrocytes,  and synovio- 
cytes (1-4). 
n__ 
A portion of this work was presented at the 17th Annual Meeting of the 
American Society for Bone and Mineral Research (Baltimore, MD, Sep- 
tember 9-13, 1995) and has been published in an abstract form (1995.J. 
Bone. Miner. Res. 10:$142). 
The IL-11 receptor is a cell surface receptor that consists 
of two components: a unique ligand-binding  150-kD gly- 
coprotein  chain  (IL-11Ro  0  (5,  6)  and a non-ligand bind- 
ing, signal transducing 130-kD glycoprotein chain (gp130p 
(7,  8).  Both  components  are  necessary  for  high  affinity 
binding and signal transduction  (6,  8).  Signaling occurs af- 
ter ligand-induced dimerization ofgpl30 that activates down- 
1Abbreviations used in this paper: 10L,25(OH)zD3, lot,25-dihydroxyvitamin 
D3; CTR, calcitonin receptor; gp130, glycoprotein  130; IL-11Rc~,  IL-11 
receptor; IL-6Rcq IL-6 receptor; LIF, leukemia inhibitory factor; OCL, 
osteoclast-like multinucleated cell; OSM, oncostatin M; PTH, parathy- 
roid hormone; slL-6Rc~, soluble IL-6  receptor; TRAP, Tartrate-resistant 
acid phosphatase. 
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ily of non-receptor kinases and a latent transcription factor, 
acute phase response factor or signal transducer and activa- 
tor of transcription factor 3  (APRF/STAT 3)  (9,  10).  The 
gp130 signal transducer mediates  biological effects exerted 
not only by IL-11, but also IL-6, oncostatin M  (OSM), leu- 
kemia  inhibitory  factor  (LIF),  ciliary  neurotrophic  factor 
(CNTF), and cardiotrophin-1  (CT-1)  (11,  12). 
Several lines of evidence suggest that IL-11 is an impor- 
tant osteotropic factor. IL-11 receptor transcripts are present 
in  chondroblastic  and  osteoblastic  progenitor  cells  during 
mouse embryogenesis (13).  IL-11 itself is produced by hu- 
man osteosarcoma SaOs-2 cells  (14), and Girasole et al.  (15) 
showed that IL-11 dose-dependently stimulated osteoclast- 
like multinucleated  cell  (OCL)  formation in cocultures  of 
mouse  osteoblasts  and  bone  marrow  cells.  They reported 
that monoclonal anti-IL-11 antibody inhibited osteoclast for- 
mation induced by several osteotropic factors. We also re- 
ported  that IL-11, IL-6 together with  its  soluble  IL-6 re- 
ceptor  (slL-6Rcl),  OSM  and LIF similarly triggered  OCL 
formation in cocultures (16,  17). 
These  observations  focus interest  on the  modulation of 
IL-11  and  its  receptor  during  OCL  development.  In the 
present  study,  we  measured  IL-11  production by primary 
mouse calvarial cell cultures using a novel bioassay based on 
the  expression  of functional  IL-11  receptors in Ba/F3  cells 
(6).  We  examined  the  effects of IL-1, TNFa,  PGE  2, par- 
athyroid hormone (PTH) and lci,25-dihydroxyvitamin D3 
[1ci,25(OH)zD3],  all  of which  induce  OCL  formation  in 
mouse  cocultures.  The  role  of gp130-mediated  signals  in 
OCL formation was determined using a rat monoclonal anti- 
mouse gp130 antibody.  The  expression  of gp130  and  IL- 
11R0~  mRNA  was  studied  by Northern  analysis  and  re- 
verse transcription-PCR,  respectively.  The  distribution  of 
IL-111Kci transcripts  was investigated by in situ  hybridiza- 
tion. 
We  found  that  osteotropic  factors  induced  IL-11  pro- 
duction by osteoblasts and in addition, modulated steady-state 
levels of osteoblast gp130 mRNA. Interleukin-11  receptor 
transcripts  were  detected  in  osteoblasts  and  osteoclast-like 
cells.  In the present study we demonstrate that gp130-me- 
diated signals are critical cofactors for osteoclastogenesis in- 
duced by a variety of bone resorbing factors. 
Materials and Methods 
Animals and Cytokines.  Newborn  and  6-9-wk-old male  C57/ 
B16J mice were purchased from Monash University Animal Ser- 
vices Center (Clayton, Australia). Recombinant human IL-11  (spe- 
cific activity 10  s U/rag protein)  was obtained from Dr. T. Willson 
(Walter  and Eliza Hall Institute,  Melbourne, Australia).  Neutral- 
izing monoclonal murine anti-human IL-11 antibody was gener- 
ously provided by Genetics Institute (Cambridge, MA). Recom- 
binant  mlL-11,  mlL-6,  hOSM,  mlL-3,  raiL-4,  hLIF, mlL-lo~, 
and mTNFei were purchased from Peprotech (Rocky Hill,  NJ). 
Mouse slL-6R was prepared from CHO cells as described (16). Re- 
combinant hTGF[31  was the gift of Genentech Inc.  (San Fran- 
cisco, CA). kx,25(OH)2D3 was obtained from Wako Pure Chemical 
Co. (Osaka, Japan). Bacterial collagenase was obtained from Worth- 
ington Biochemical Co. (Freefold, Australia). Other chemicals and 
reagents were of analytical grade. 
Cell Culture and Determination of Osteoclast Characteristics.  To  iso- 
late osteoblastic cells, 6--10 calvaria obtained from 1-d-old mice were 
cut into small pieces in 10-cm culture dishes with 5 ml of cI-MEM 
(GIBCO BRL, Gaithersburg,  MD) containing 30% FBS (Cytosys- 
tems,  Castle  Hill,  NSW, Australia).  Type-I collagen  gel solution 
(70%, 5 ml) (Cellmatrix  Type I-A; Nitta Gelatin  Co., Osaka, Ja- 
pan) was added in the culture dish according to the manufactur- 
ers' instructions.  After culture for 4-6 d, osteoblastic  cells grown 
from the calvaria were collected by treating with PBS containing 
0.3% collagenase for 20 min at 37~  (17). These freshly isolated 
osteoblastic  cells were cocultured with bone marrow cells as de- 
scribed  (16, 17). In short,  primary osteoblastic  cells (104 per well) 
and nucleated marrow cells (2 ￿  105 per well) were cocultured in 
48-well plates (Coming Glass Ins., Coming, NY) with 0.3 ml of 
ci-MEM containing 10% FBS in the presence of test  chemicals. 
Cultures were incubated in quadruplicate and cells were replenished 
on day 4 with flesh medium. OCL formation was evaluated  after 
culturing for 6 d.  For tartrate-resistant  acid phosphatase  (TRAP) 
staining,  adherent cells were fixed with 4% formaldehyde in PBS 
for 3 min. After treatment with ethanol-acetone (50/50, vol/vol) 
for 1 rain,  the well surface was air dried and incubated for 10 min 
at room temperature in an acetate  buffer (0.1 M  sodium acetate, 
pH  5.0)  containing  0.01%  napthol  AS-MX phosphate  (Sigma 
Chem.  Co., St.  Louis,  MO) as a substrate  and 0.03%  red violet 
LB salt (Sigma) as a stain for the reaction product in the presence 
of 50 mM sodium tartrate.  TRAP positive cells appeared  as dark 
red cells. The expression  of calcitonin receptors  (CTP,)  was as- 
sessed by autoradiography using  [12sI]-salmon calcitonin  as  de- 
scribed (16-20). 
Mouse bone marrow cell cultures  were prepared as described 
(18, 20). The marrow cells were plated at 1 ￿  106 cells/ml and in- 
cubated in c~-MEM containing 12.5% FBS in 9-cm petri dishes 
(Nunc, Inc. Naperville, IL). OCL formation  was induced by lo~,25 
(OH)2D 3 (10 nM), added on the first day and every third day there- 
after, when half the medium was replaced with fresh medium. In 
parallel cultures,  the cells were cultured on top of 13-ram Ther- 
manox coverslips  (Nunc) for enumeration of OCLs by TRAP- 
staining and [~2sI]-calcitonin binding. 
For in situ hybridization, after coculturing on collagen  gels for 
7 d (19), cells were treated with collagenase  (0.2%), and subcul- 
tured on top of 13-mm diameter Thermanox coverslips  (Nunc) 
in 24-well plates, before processing. 
A stock of the mouse bone marrow-derived stromal  cell line 
ST2 (21, 22), was obtained from RIKEN cell bank (Tsukuba, Ja- 
pan). ST2 cells in the 12th passage were grown to sub-confluence in 
75-cm  2 tissue culture flasks (Nunc), in phenol red-flee ot-MEM 
containing 10% FBS. The medium was changed to 2% FBS over- 
night, and cells were treated with osteotropic factors before extrac- 
tion of total RNA at the appropriate times. 
Biological Assay for IL- 1I.  IL-11  activity was  measured using 
the Ba/F3 cell microproliferation assay (6, 23). Survival and pro- 
liferation  of Ba/F3 cells are supported by IL-3, and also by IL-11 
after transfection  with cDNAs for mlL-111kcx and gp130. Trans- 
fected cells also respond to high concentrations of the complex of 
mlL-6 and slL61Kot (3 p,g/ml IL-6 and 500 ng/ml slL-6Rot, re- 
spectively),  but do not proliferate  in response  to OSM,  IL-6, or 
LIF (6). The cells did not show effects with other cytokines or re- 
agents  used  in the present  study.  Ba/F3  clones  were  grown in 
DME containing 10% (vol/vol) FBS and 10% (vol/vol) WEHI- 
3B D-conditioned medium as a source of IL-3 (24). Cells were 
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growth  phase.  Cell proliferation was  measured in  Lux-60  mi- 
crowell HL-A plates (Nunc).  For use, Ba/F3 cells were washed 
three  times in DME  containing 20%  (vol/vol) FBS  and resus- 
pended at a  concentration of 20,000  cells/ml in the same me- 
dium.  10-~1 aliquots of cell suspension were then placed in the 
culture wells with 5  I.U of serial dilutions of recombinant IL-3, 
IL-11, or culture supematants. After 2 d of incubation at 37~  in 
a fully humidified incubator containing 10%  CO  2 in air, viable 
cells were counted using an inverted microscope. IL-11 concen- 
trations  in  the  supernatants  were  determined from  a  standard 
curve set up with known  amounts  of recombinant IL-11. The 
detection limit of this assay was typically 50-100 pg/ml (Fig. 1). 
ELISAfor slL6Ra.  Concentrations of slL-6Ret were  deter- 
mined by a sandwich ELISA using rat monoclonal anti-mlL-6Ra 
antibody and rabbit polyclonal anti-mlL-6Ra antibody, as  de- 
scribed (25). The detection limit of this assay was 1 ng/ml. 
Northern Analysis.  Total cellular RNA was extracted using the 
guanidine thiocyanate-phenol chloroform method (26), fraction- 
ated by electrophoresis on 1.5% agarose-formaldehyde gels (20 Ixg/ 
lane), and transferred to nylon membranes  (Hybond-N; Amer- 
sham Corp., Arlington Heights, IL). A 2.7-kb mouse gp130 cDNA 
(27) was random prime labeled with [32p]dCTP to a specific activity 
of I  ￿  109 U/min/mg DNA (Boehringer Mannheim, Mannheim 
GmbH, Germany). Hybridization and washing were carried out 
as previously described (28). Specifically  bound cDNA was quan- 
tified using a Phosphorlmager and ImageQuant software (Molec- 
ular Dynamics, Sunnydale, CA). Relative mRNA levels were nor- 
malized for loading variability  by comparison with 18S ribosomal 
RNA levels in the same membranes, probed with a 32p-labeled 
18S ribosomal RNA oligonucleotide. 
PCR Amplification of Reverse-transcribed mRNA.  Expression  of 
IL-11R~x,  IL-6Ret, and calcitonin receptor (CTR)  mRNA  re- 
verse-transcribed from primary osteoblasts or bone marrow  cell 
cultures were determined by PCR and Southern blot analysis. First 
strand cDNA was synthesized from 2.5 I-~g  of total RNA by incu- 
bation for 1 h at 42~  with 12 U  of avian myeloblastosis virus re- 
verse transcriptase (Promega Corp., Madison, WI) after random 
hexanucleotide priming. The reaction mixture (25 Ixl) was made 
up to 100 Ixl with sterile distilled water, and 10 I~1 (1/10) were sub- 
mitred for PCR to amplify the sequences of the mouse IL-11Ra, 
IL-6Rcx, CTR, and GAPDH mRNAs specified below. The re- 
action mixture contained 50 pmol of each primer, 0.25 mM dATP, 
dGTP,  dCTP,  and  dTTP  (Pharmacia, Uppsala,  Sweden),  2  I~1 
10￿  reaction buffer,  1 U  of Taq DNA polymerase (Boehringer 
Mannheim) and sterile distilled water, and was overlaid with 50 ~1 
of paraffin oil. PCR for CTR,  IL-11Rcx, and IL-6Rcx was per- 
formed in a DNA Thermal Cycler 480 (Perkin-Elmer Cetus In- 
strs., Norwalk, CT) as described (17). To permit semiquantitation 
of the PCR products, preliminary experiments were performed 
to ensure that the number of PCR cycles employed for each prod- 
uct in a given experiment (described in the legends to Figs. 5 and 
9)  was  within the  exponential phase  of the  amplification curve. 
PCR products were resolved on a 2% wt/vol agarose gel and the 
specificity of the  reaction was  confirmed by  Southern  transfer 
onto nylon membranes (Hybond-N; Amersham) and hybridiza- 
tion with 32p-labeled intemal oligonucleotide probes. 
Control PCR reactions were carried out on non-reverse tran- 
scribed RNA; in none of these samples were PCR products de- 
tected. 
Oligonucleotides were synthesized on an Applied Biosystems 
DNA synthesizer model 381A (Foster City, CA). The oligonu- 
cleotides for mouse IL-6Ro~ (17) were: 5'-CCTGTGTGGGGT- 
TCCAGAGGAT-3' (3' primer complementary to nucleotides 980- 
1001) and 5'-CTGCCAGTATTCTCAGCAGCTG-3' (5' primer 
complementary to nucleotides 488-519).  The products were veri- 
fied by Southern hybridization with the internal oligonucleotide, 
5'-CACAACGAAGCGTTTCACAGCTT-3'. The oligonucleo- 
tides for mouse IL-11Ra (6,  17)  were:  5'-GGAGGCCTCCA- 
GAGGGT-3' (3' primer complementary to nucleotides 661-667) 
and 5'-GGGTCCTCCAGGGGTCCAGTATGG-3'  (5' primer 
complementary to nucleotides 133-156). The products were verified 
by  Southern  hybridization with  the  internal  oligonucleotide, 
5'-CTCCTGTACTTGGAGTCCAGG-3'. The oligonucleotides 
for  mouse  CTR  were:  5'-ACAAACTGGA(T/C)(T/G)CCC- 
AGCAGGGGCAC-3' (3' primer complementary to nucleotides 
1663-1689)  and  5'-AAGAACATGTT(C/T)CT(C/G/T)AC- 
TTA  (5'  primer complementary to  nucleotides 1058--1079),  as 
we previously reported (20). The CTR PCR products were ver- 
ified with the internal sense strand oligonucleotide, 5' -ACCAA- 
GATGAGGCAAACC-3', by Southern hybridization. 
To ensure equal starting quantities of cDNA for the experiments, 
and to allow semiquantitation of the PCR products representing 
mlL11-Ra or mlL-6Ra, the reverse-transcribed RNA samples 
were  also  amplified using  oligonucleotide primers  specific  for 
GAPDH (29). A fragment of--420 bp was amplified using 5'-spe- 
cific oligonucleotide, (5'-CATGGAGAAGGCTGGGGCTC-3', 
representing nucleotides 306-325 of rat GAPDH) and 3'-specific 
oligonucleotide, (5'-AACGGATACATTGGGGGTAG-3', rep- 
resenting nucleotides 701-720). Products were verified with [32p]_ 
labeled  internal  oligonucleotide  (5'-GCTGTGGGCAAGGT- 
CATCCC-3', representing nucleotides 640-659). The signals were 
quantitated using  a  Phosphorlmager  and  ImageQuant software 
(Molecular Dynamics). 
Preparation of Anti-Mouse gp-130 Antibody.  Wistar rats were im- 
munized with 100  I~g of soluble mouse gp130 in Freund's com- 
plete adjuvant, followed by seven 50-1xg boosts of soluble mouse 
gp130 in Freund's incomplete adjuvant once a week. 3 d after the 
last boost, the rats were sacrificed and spleen cells were fused with 
P3U1 mouse myeloma cells with polyethylene glycol 1500 (Boeh- 
ringer Mannheim). Hybridomas were established by conventional 
hypoxanthine/aminopterin/thymidine selection methods, and hy- 
bridomas producing anti-mouse gp130 were selected by flow cy- 
tometry using BAF-m130 cells, which were established by trans- 
fection of BAF-B03 cells with mouse gp130 cDNA (27). 
Briefly, culture supernatants of the hybridomas (100  I~1) were 
added to BAF-m130 cells (5  X  10  s cells) with  100  Ixl of Ca  2+, 
Mg2+-free phosphate-buffered saline containing 2%  heat-inacti- 
vated FBS and 0.1% sodium azide. The cells were incubated for 
20 min on ice, and then incubated for 20 min with FITC-conju- 
gated mouse anti-rat IgG (2 I~g/ml) on ice. Stained cells were an- 
alyzed by flow cytometry using FACScan  |  (Becton Dickinson 
Immunocytometry Sys., Mountain View, CA). Hybridomas rec- 
ognizing soluble mouse gp130 were cloned twice by limiting di- 
lution. Established hybridomas were expanded as ascite tumors in 
BALB/C  nude  mice,  and  the  antibody was  purified from  the 
fluid with protein G-agarose column  (Oncogene Science, Inc., 
Manhasset, NY). 
Synthesis of Riboprobe.  A  riboprobe for mouse  IL-11Ra was 
synthesized and labeled with digoxigenin (DIG) by using a RNA 
labeling kit (Boehringer Mannheim)  according to the manufac- 
turer's instructions. A 1350-bp PCR fragment in the BstXI site of 
the  mammalian expression vector pEF-BOS  (6)  was subcloned 
into the XbaI site of pBluescript (Stratagene, Inc., La Jolla, CA). 
The antisense and sense probes were then obtained after lineariza- 
tion of the plasmid with Sinai for T3 and NotI for T7 RNA poly- 
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probe for its target sequence was verified by Northern analysis of 
total RNA derived from transfected  Ba/F3 cells. 
In Situ Hybridization.  In situ  hybridization was performed as 
described  with minor modifications (30). Cocultures established 
on top of 13-mm coverslips in 24-well plates were rinsed in ice- 
cold PBS, and fixed in 4% paraformaldehyde (PFA) in PBS for 30 
rain. After washing in PBS, they were pretreated with 0.2 M HC1 
for 20 min, washed with sterile distilled water for 10 min, and di- 
gested  with 5 p,g/ml proteinase  K  (37~  30 rain)  in PBS. After 
treatment with 2 mg/ml of glycine in PBS to inactivate  protein- 
ase K, they were refixed with 4% PFA-PBS for 15 rain.  Hybrid- 
ization was carried  out with 2-4 ng/p~l of antisense  cRNA in a 
damp  chamber  in  a  solution  containing  50%  formamide,  5￿ 
SSC,  2% blocking reagent  (Boehringer Mannheim),  0.02%  so- 
dium  dodecyl sulfate,  and  0.1%  N-lauroylsarcosyl,  for  18  h  at 
42~  After hybridization,  coverslips  were  washed  sequentially 
with  2￿  SSC for 30 rain,  treated with  20  ~g/ml ribonuclease 
(RNase, DNase free; Boehringer Mannheim) in 2￿  SSC for 30 
rain to remove excess cRNA, then washed with 1￿  SSC for 30 
min, and finally with 0.1 ￿  SSC for 30 rain.  Detection of hybrid- 
ized probe was  with  the  anti-DIG-alkaline  phosphatase  conju- 
gate, according to the manufacturer's instructions.  The coverslips 
were rehydrated in ethanol, and counterstained with nuclear fast 
red before mounting. 
Cytospin preparations  oftransfected Ba/F3 cells served as posi- 
tive controls.  Hybridization specificity was verified by elimination 
of signals after pretreatment with 100 ~g/ml of  RNase for 1 h be- 
fore hybridization with antisense riboprobe. 
Statistical  Analysis.  Statistical significance was determined by Stu- 
dent's t test. 
Results 
Regulation  of IL-11  Production  by  Primary  Murine  Osteo- 
blasts.  We first analyzed IL-11 production by primary os- 
teoblasts derived from mouse calvaria. Subconfluent osteo- 
blasts  were incubated  in ot-MEM  containing  10%  FBS in 
the  presence  or absence  of osteotropic  factors,  and  IL-11 
activity  in  the  culture  supernatants  was  quantitated  using 
the Ba/F3 bioassay. Fig.  1 shows the effect of graded con- 
centrations ofrhlL-11 on the viability oftransfected Ba/F3 
cells  expressing the raiL-11Rot chain and gp130  (le~), and 
the  neutralization  of this  response  by monoclonal murine 
anti-human  IL-11  antibody  (otlL-11  mAb,  right). Parental 
Ba/F3  cells  did not respond to rhlL-11,  whereas both pa- 
rental and transfected cells proliferated in response to rmlL-3 
(data not shown). The specificity of this microassay depended 
on the parallel response of transfected and parental cells. 
Using this assay, it was clear that unstimulated osteoblasts 
produced levels oflL-11 that were below the limits of detec- 
tion in our assays. In contrast, cells that were stimulated with 
raiL-lot,  mTNFot,  PGE2,  PTH,  and  10t,25(OH)2D 3 pro- 
duced readily detectable levels of IL-11. As seen in Fig. 2, 
the time-dependent  effects of IL-1, TNFot,  or PGE  2 were 
appreciated  only after incubation for 6  h,  and were  near- 
maximal after 12-h incubation.  The levels of IL-11 present 
after PTH or lot,25(OH)2D3 stimulation were not maximal 
before 24 h. 
Fig.  3  demonstrates  the  dose-dependent  nature  of these 
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Figure  1.  Left  panel shows a microassay for Ba/F3 cell proliferation. 
Transfected Ba/F3 cells expressing the mlL-111~t chain and gp130 were 
incubated at 200 cells per well in a volume of 15 p~l with the indicated 
amounts ofrhlL-11. After incubation for 48 h the numbers of  viable cells 
were counted. In parallel incubations, parental Ba/F3 cells were non-via- 
ble (not shown). Right panel shows the effect of  graded concentrations of 
monoclonal murine anti-human IL-11 antibody ((xlL-11 mAb) on the re- 
sponse oftransfected Ba/F3 cells to rhlL-11 (1.0 ng/ml). 
responses.  The  effects of IL-1  or TNF  were  evident with 
concentrations as low as 0.1  ng/ml  (the lowest concentra- 
tion tested).  Doses as low as  10 pM  1ot,25(OH)2D3 and 25 
ng/ml ofhPTH (1-34) induced IL-11. Importantly, the abil- 
ity to induce IL-11 release from osteoblasts was not a gen- 
eral property of all  osteotropic cytokines, since raiL-6  (20 
ng/ml),  hOSM  (20 ng/ml),  hTGF]3  (1  ng/ml),  or raiL-4 
(10 ng/ml) did not elicit IL-11 release  (Fig. 3).  The effects 
oflL-1 and TNFot on IL-11 production were abolished by 
incubating with the  cyclooxygenase inhibitor indomethacin 
(10  -6 M), but the effects of PGE  2, PTH, or 1ot,25(OH)2D3 
were not (data not shown). Thus, prostaglandins seemed to 
be involved in IL-11 production induced by IL-1 and TNF 
in these cultures. Indeed PGE  2 itself potently induced IL-11 
production by osteoblasts (Figs.  2 and 3). 
In view of the possibility that  slL-6Rot present  in  con- 
junction  with  IL-6 might  also  have  stimulated  the  trans- 
fected Ba/F3 cells,  we assayed the slL-6Rot concentrations 
by ELISA. In none of the  culture supernatants  from these 
experiments was slL-6Rc~ detectable (detection limit 1 ng/ml; 
data not shown). In contrast, the growth activity in the su- 
pernatants  was completely neutralized by monoclonal mu- 
fine  anti-human  IL-11  antibody  (Table  1).  Together,  this 
evidence indicated that the activity in the culture superna- 
tants measured by the  microassay was due  to the presence 
of IL-11. 
Endogenous IL- 11 Production in Cocultures of Mouse Bone Mar- 
row Cells and Primary Osteoblasts.  In view of the importance 
of lot,25(OH)2D 3  in  mediating  osteoclastogenesis  in  the 
mouse coculture system (31-33), and the apparent ability of 
monoclonal anti-human IL-11 antibody to abrogate osteo- 
clast formation (15), we measured the effect of lot,25(OH)2D 3 
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Figure  2.  IL-11 production  by primary osteo- 
blasts. Subconfluent murine  osteoblasts were  cul- 
tured for up to 48 h in the absence (unstimulated) 
or presence of mlL-let (5 ng/ml), mTNF0t (10 ng/ 
ml),  PGE  2  (10  .6  M),  PTH  (200 ng/ml),  or 
lot,25(OH)2D  3 (10 nM). IL-11 released into the su- 
pernatants was quantitated at each time point using 
the Ba/F3 cell bioassay. Each value represents the 
IL-11 bioactivity (mean + SE) of  triplicate cultures. 
Unstimulated osteoblasts did not release detectable 
IL-11 at any time point (data not shown). These re- 
sults are representatives of replicate experiments. 
on endogenous IL-11  production in cocultures. As shown 
in Fig. 4, treatment with 10 nM  1et,25(OH)2D 3 resulted in 
striking accumulation of IL-11 in the supematants,  signifi- 
cantly different from untreated cocultures, in which IL-11 
was not detected. 
Expression of Transcripts for ILol 1Ra Chain  and gp130 by 
Primary Osteoblasts.  Since functional responses to IL-11 are 
dependent  not  only  on  local production  of the  cytokine 
but also expression of its specific receptors, we next deter- 
mined  expression  of IL-11  receptor mR.NAs  by primary 
osteoblasts.  As  shown  in  Fig.  5,  these  cells constitutively 
expressed transcripts for IL-11Rot and gpl30. By the semi- 
quantitative 1KT-PC1K procedure, no modulation oflL-111kc( 
mlKNA relative to GAPDH mlKNA was apparent after 24 h 
stimulation with  1ot,25(OH)zD3, PTH,  or IL-1. However, 
Northern analysis revealed that steady-state gp130 mR.NA 
levels were  upregulated.  Thus,  after 24  h  1ot,25(OH)2D 3 
(10  nM)  and  PTH  (200  ng/ml)  elevated gp130  mRNA 
levels 3.1-  and  1.7-fold above control,  respectively. Simi- 
lady, IL-1 (10 ng/ml) upregulated gp130 mlKNA levels 2.4- 
fold above unstimulated osteoblasts. 10t,25(OH)ED3 also up- 
regulated gp130 mRNA  in ST2 cells, a clonal mouse stromal 
cell line that is capable of supporting osteoclast formation (21, 
22).  In  contrast,  other  steroid  hormones  (13-Estradiol  or 
Dexamethasone)  did not affect steady-state gp130  mlKNA 
in ST2 cells (Fig. 6). 
Effects of Murine Monodonal Anti-gp130 Antibody  on Osteo- 
dast Formation.  To establish that gp130-mediated signal trans- 
duction is required for osteoclast formation by IL-6 or IL-11, 
we prepared a rat monoclonal anti-mouse gp130 antibody. 
The antibody was used to define the role of gp130-medi- 
ated  signals  in  osteoclast formation.  As  shown  in  Fig.  7, 
graded concentrations of gp130 antibody added to murine 
cocultures dose-dependendy inhibited osteoclast formation 
induced by mlL-6  (20 ng/ml)  in combination with smlL- 
61k(x (500 ng/ml), or IL-11 (10 ng/ml). We established that 
10  Ixg/ml of the  antibody completely neutrahzed  the  os- 
teoclastogenic activity of each cytokine. More importantly, 
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Figure  3.  IL-11 production  by primary osteo- 
blasts. Subconfluent osteoblasts were  cultured for 
48 h in the absence (unstimulated) or presence of 
the indicated concentrations of raiL-lot, mTNF(x, 
PGE  2, PTH, or 1ot,25(OH)2D  3. IL-11 released into 
the supematants was quantitated using the Ba/F3 
cell bioassay.  Each value represents  the IL-11 bioac- 
tivity (mean +  SE) of triplicate cultures. Neither 
traiL-6 (20 ng/ml), rhOSM (20 ng/ml), rhTGF~I 
(1 ng/ml), or rmlL-4 (10 ng/ml) induced IL-11 re- 
lease. The results are representatives  of rephcate ex- 
periments. 
2585  Romas et al. Table  1.  Specificity  of the Ba/F3 Microassay  for IL- I 1 in 
Osteoblast Culture Supernatants 
Culture supernatant  (48 h) 
cllL-ll mAb added 
(20 I-~g/ml) 
-  + 
No stimulation  3  ---  1  0 
IL-1  (5 ng/ml)  94  _+ 9  6  -+ 2* 
TNFot (10 ng/ml)  90  --Z- 14  7  -  3* 
PGE  2 (10 -6 M)  115  _+  16  9  _  2* 
hPTH (200 ng/ml)  82  +  5  6  +  2* 
lot,25(OH)2D 3 (10 nM)  63  +  6  4  -  2* 
Transfected  Ba/F3  cells were maintained for 48 h  in the presence  of 
culture supernatants  (diluted  1:2) derived from primary osteoblastic cells 
treated for 48 h, without or with monoclonal murine anti-human IL-11 
antibody (20 Ixg/ml).  Values shown represent the mean  +  SE number 
of  viable Ba/F3 cells per well from four replicate  wells. 
*P <0.005 vs cells cultured in the absence of monoclonal murine anti- 
human IL-11 antibody (odL-11 mAb). 
Figure  5.  Expression oflL-11Rot and gpl30 mRNAs by primary  os- 
teoblasts. Osteoblasts were  cultured  without  additions  (control) or with 
let,25 (OH)2D  3 (10 nM), hPTH (200 ng/ml) or IL-let (10 ng/ml) for 24 h. 
Total  RNA  was  reverse  transcribed  and  amplified  by  30  cycles  for 
IL-t 1Ret and  20  cycles for mouse GAPDH rnRNA using the specific 
primers described in Methods.  PCR products  were transferred to a nylon 
membrane and hybridized with 32P-labeled internal oligonucleotides specific 
for mlL-11Rot and GAPDH sequences respectively. For Northern analy- 
sis, total RNA (20 I~g/lane) was hybridized  to 32p-labeled gp130 cDNA. 
Hybridization  with 32p-labeled oligonucleotide  specific to 18S sequences 
was used to control for equivalence  of loading. The number above each 
lane is the treated/control ratio of the intensity of the band(s) normalized 
to that of GAPDH or 18S RNA, measured by densitometry. 
the anti-gpl30  antibody  abolished  osteoclast formation in- 
duced  by  IL-lo~ (1  ng/ml)  and  inhibited,  by between  60- 
75%,  osteoclast formation induced by PGE2  (10  -6 M),  lcl,25 
(OH)2D 3  (10  nM),  or  hPTH  (1-34)  (400  ng/ml)  (Fig.  8) 
suggesting a  common  role of gp130  signals for osteoclasto- 
genesis induced by several bone-resorbing  factors.  In these 
experiments,  an  equivalent concentration  of non-immune 
IgG did not inhibit osteoclast formation (data not shown). 
IL- 11Rce Transcript Expression  in Cells of the Osteoclast Lin- 
eage.  To investigate the possibility that OCLs as well as bone 
marrow progenitors  also  express  mRNA  for IL-11Rot,  the 
temporal relationship of the expression of IL-11Rot to CTR 
mRNA  was  studied  during  osteoclast  formation  in  bone 
marrow  cell cultures.  As shown  in Fig.  9,  fresh bone mar- 
row  cells  (day  0)  constitutively  expressed  IL-11RoL  tran- 
3000 
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Figure  4.  Effect  of  lot,25- 
(OH)2D 3 on IL-11 production in 
cocultures  of primary  osteoblasts 
and  bone  marrow  cells. Cocul- 
tures were maintained  for 6 d in 
the absence (unstimulated,  --~--) 
or  presence  (--II--)  of  lc1,25 
(OH)2D  3  (10  riM),  with  a  com- 
plete medium change after incuba- 
tion  for 3  d.  At the  times  indi- 
cated,  50  bd  of  the  culture 
medium was collected for quan- 
titation  oflL-11 using the Ba/F3 
cell bioassay. The amount of IL- 
11 present  4 and 6 d after initia- 
tion of the culture was calculated 
by  adding  the  IL-11  level  ob- 
tained  at  day  3  to  the  absolute 
amounts  determined  at those times. Each point represents the mean cu- 
mulative  IL-11  bioactivity  of triplicate  cultures.  *P <0.005  vs unstimu- 
lated cultures. 
scripts.  When  cultures  were  stimulated  by  10  nM  lc~,25 
(OH)2D3,  a  time-dependent  increase  in  CTR  mRNA  (28 
cycles of PCR  amplification),  relative to  GAPDH  mRNA 
(20 cycles of PCR  amplification) occurred, reflecting differ- 
entiation of bone marrow cell progenitors,  as mature osteo- 
clasts were plentiful in the cultures  after 5  d.  More impor- 
tantly, after 10 d, we consistently detected a parallel sevenfold 
rise in abundance  of IL-11Rot transcripts  (30 cycles of PCR 
amplification)  relative  to  GAPDH  mRNA,  beginning  at 
day 4  to 5.  This phenomenon  was relatively specific for IL- 
11Rot mRNA,  as evidenced by the lack of appreciable change 
in abundance  of IL-6R(x mRNA  (25  cycles of PCR  ampli- 
fication) relative to GAPDH  mRNA  (Fig. 9).  This sequen- 
tial  relationship  between  CTR  mRNA  and  IL-11Rc~ 
rnRNA  expression  suggested  that  expression  of IL-11Rcx 
mRNA  was  upregulated  during  OCL  differentiation.  To 
test this hypothesis,  and to verify IL-11Ro~ gene expression 
by osteoblasts,  we carried out in situ hybridization. 
Cocultures  grown  on  collagen  gels  were  treated  with 
1oL,25(OH)2D3  for  7  d,  transferred  to  coverslips  (18)  and 
Figure  6.  Effects  of  steroid 
hormones  on gp130 mRNA ex- 
pression by ST-2 cells. Subcon- 
fluent  cells were cultured  for 24 
or 48 h under 2% serum condi- 
tions in phenol red free cx-MEM 
without  additions  (control)  or 
with  lot,25(OH)2D 3  (10  nM), 
t3-Estradiol  (10  nM)  or  Dexa- 
methasone (10  -7 M, Dex). 20 Ixg/ 
lane  of fractionated  total  RNA 
was hybridized  with 32p-labeled gpl30 cDNA, as described in Materials 
and Methods.  The number in each lane is the treated/control ratio of the 
intensity  of the  bands normalized  to  that  of 18S  RNA,  measured  by 
densitometry. 
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Effect of monoclonal anti-mouse  gp130  antibody  on OCL  Figure  7. 
formation  induced by mlL-6-slL-6tLo~, or mlL-11.  Cocu|tures of bone 
marrow cells and primary osteoblasts were maintained  in the presence of 
raiL-6 (20 ng/ml) in combination with smlL-6tLc~ (500 ng/ml), or miL- 
l 1 (10 ng/ml). Simultaneously, graded concentrations  ofanti-gpl30 anti- 
body were added,  as indicated.  After culturing  for 7  d, TRAP-positive 
cells were counted.  Data are expressed as the mean -+ SE total number of 
TRAP-positive cells (OCLs) per well of quadruplicate  cultures. Pretreat- 
ment with non-immune lgG had no effect on osteoclast formation  (data 
not shown). These results are representatives of four separate experiments. 
then  processed  for  in  situ  hybridization.  As  illustrated  in 
Fig.  10  A,  these  cocultures  contained  IL-11tLo~ transcripts 
detectable by in situ hybridization.  Indeed, both osteoblasts 
and  OCLs  expressed IL-11R.e~ mRNA.  IL-1 ltLa transcripts 
were located predominantly  in  OCLs,  which  were  identi- 
fied by morphology and  TRAP-staining  (data not shown). 
The  specificity of this  result was  verified by elimination  of 
hybridization signals after pre-treatment  with 100  ~g/ml  of 
ribonuclease for 1 h  (Fig.  10 B). 
Figure  9.  Effect  of  1c~,25- 
(OH)2D  3  on  raiL-liRa,  mlL- 
6Ro~, and  mCTR  mP,.NA  ex- 
pression  in  bone  marrow  cell 
cultures.  Bone  marrow  cells 
were  cultured  for  10  d  in  the 
presence  of le~,25(OH)2D  3  (10 
nM).  At each time point,  osteo- 
clasts  were  enumerated  as  de- 
scribed  in  Materials  and  Meth- 
ods. RNA was reverse transcribed 
and  subjected  to  30  cycles  of 
PCR.  for mIL-11RoL amplifica- 
tion,  25 cycles of PCR for mIL- 
6Ra  mRNA  amplification,  28 
cycles  of  PCR.  for  mCTP~ 
mRNA  and  20  cycles  of PCR 
for GAPDH rnKNA, using spe- 
cific  primers.  PCR.  products 
were resolved by electrophoresis, 
transferred to nylon membranes, 
and  hybridized  with  specific 
[32p]-labeled internal oligonucle- 
otides  as  described  in  Materials 
and  Methods.  Upper  panel 
shows  timed  appearance  of os- 
teoclasts  in  the  cultures.  Each 
value represents  the mean  +  SE 
of  osteoclasts  (cells exhibiting 
both TRAP staining and  [~2sI]-CT binding)  per well from four replicate 
cultures.  Middle panel shows PCIL products  for mlL-11tLc~, mlL-6Rc~, 
and CTR, at parallel time points. To allow semiquantitation  of the PCR 
products, reverse transcribed tLNA was also amplified using primers com- 
plementary  to  GAPDH  sequences.  The  intensities  of autoradiographic 
signals for  mlL-11P,.~x, mlL-6Ra,  and  GAPDH  PC1L products  were 
quantitated  and are shown in the lower panel as the ratio of rolL-1 ltLc~/ 
GAPDH and mlL-6Ra/GAPDH. This figure is a representative  of three 
separate experiments;  similar results were obtained  in the other two ex- 
periments. 
Discussion 
The  present  study  focused  on  the  regulation  of IL-11 
synthesis  by  primary  osteobhsts  and  furthers  our  under- 
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Effect of monoclonal anti-mouse  gp130 antibody  on osteo-  Figure 8. 
clast formation  stimulated by 1L-l,  PGE2, PTH, or 1ot,25(OH)2D  3. Co- 
cultures  of bone marrow  cells and primary osteoblasts were maintained in 
the presence oflL-l~ (I ng/ml), PGE2(10  -6 M),  lc~,25(OH)2D  3 (10 nM), 
or  hPTH  [1-34] (400 ng/rrd),  each  without  or  with  the  indicated 
amounts  of anti-gp130  antibody  added simultaneously at the begining of 
the culture.  After culturing  for 7 d, TRAP-positive cells were counted. 
Data are expressed as the mean +  SE total number of TRAP positive cells 
(OCLs) per well ofquadruphcate cultures. Pretreatment  with nonimrnune 
IgG did not influence  osteoclastogenesis (data not shown).  These results 
are representatives of five separate experiments. 
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standing  of the role  of gp130  signal transduction  in  osteo- 
clast formation.  IL-11  receptor transcripts were detected not 
only in osteoblasts,  but in mature osteoclasts, indicating that 
both  bone  forming  and  bone  resorbing  cells  are  potential 
targets of IL-11. 
Primary calvarial cell cultures consist of the heterogeneous 
osteoblastic-stromal  cells that are likely to be present in the 
bone microenvironment in vivo. IL-11  production  by pri- 
mary osteoblasts was induced by IL-1, TNFe~, PGE2, PTH, 
and  1a,25(OH)2D3,  all of which  are potent  osteoclastoge- 
nic factors in vitro. Unlike osteosarcoma cells (14),  primary 
osteoblasts did not produce  IL-11  constitutively. However, 
our  data  indicate  that  appropriately  stimulated  normal  os- 
teoblasts  are a  source  of this  cytokine.  Although IL-11  was 
measured with a  transfected  cell line that is potentially sen- 
sitive to growth stimulation by IL-6-slL-6R~ complexes (6), 
we  did  not  detect  slL-6R0~  in  our  experimental  systems. 
We  have previously shown  that  slL-6tL0~  also  is  undetect- 
able  in  murine  cocultures  despite  dexamethasone  stimula- 
tion, which greatly enhanced expression of osteoblast IL-6Rc~ 
mRNA  and OCL  formation  (17). 
Prostaglandin  E2 was a potent inducer of IL-11  produc- 
tion by osteoblasts,  and PGs seemed to mediate  IL-11  pro- Figure 10.  In situ hybridization. 
Cocultures of bone marrow cells 
and  primary osteoblastic cells 
were subjected to in situ hybrid- 
ization  as  detailed in  Materials 
and Methods. (A)  Photomicro- 
graph of cells from the cocultures 
at day 7. The cells were hybrid- 
ized with an anti-sense riboprobe 
specific for  mlL-11Rec  Tran- 
scripts for IL-11tkcl, represented 
by blue staining, are located in 
polygonal and spindle-shaped os- 
teoblastic-strornal  cells  (arrow 
heads)  and  OCLs (arrows).  (13) 
Specific  hybridization  signals 
were eliminated by pretreatment 
with  tLNase. All  preparations 
were  counterstained with nu- 
clear fast  red. Original  magnifica- 
tion, ￿  The  results shown in 
this figure were reproduced in 
three independent experiments. 
duction stimulated by IL-1 and TNF in our primary osteo- 
blast cultures. Prostaglandins are produced in bone by many 
cells,  especially by osteoblasts, and production is stimulated 
by a variety of cytokines derived from macrophages or he- 
mopoietic cells (34-38). The important role of PGs in IL-1- 
mediated  osteoclast  formation  and  bone  resorption  has 
been emphasized  (39),  and PGs appear to  be essential for 
IL-11 mediated osteoclastogenesis as well (15).  An IL-1 re- 
sponse element exists close to the IL-11 gene and, in cer- 
tain stromal cells IL-1 can stimulate IL-11 by a mechanism 
independent ofprostaglandins (40). 
In the present study, the ability of lot,25(OH)2D  3 to po- 
tently stimulate IL-11 production was shown in osteoblasts 
and in cocultures of osteoblasts  and bone marrow cells. These 
findings are consistent with a similar effect of la,25(OH)2D 3 
in bone  marrow cell cultures  (15).  The  concentrations  of 
IL-11 present in supernatants of the co-cultures treated with 
1ot,25(OH)2D3  exceeded  1 ng/ml after 3  d,  which was in 
accord with  our previous estimate of the EC50  of exoge- 
nous IL-11  (~1.0 ng/ml) necessary for maximal osteoclas- 
togenesis in such cocultures (16). 
Cytokines  exert  their  pleiotropic  effects by  interacting 
with specific cell surface receptors  (11,  12).  There is little 
direct information about the IL-11 receptor in connective 
tissue cells.  During embryogenesis, primitive chondroblas- 
tic and osteoblastic progenitor cells seem to express higher 
levels of a transcript homologous with IL-11Rot compared 
to  their more differentiated counterparts  (13).  Our results 
indicate  that primary osteoblasts not  only are  a  source  of 
IL-11, but express transcripts for the complete IL-11 recep- 
tor complex (IL-11Rot and gp130). This evidence suggests 
that IL-11  acts in an autocrine-paracrine fashion.  Stimula- 
tion  of primary osteoblastic cells  by l&,25(OH)2D3,  PTH 
or IL-1 upregulated gp130 mP,  NA up to threefold at 24 h, 
while mRNA levels for IL-11tkot were unchanged.  Similar 
upregulation of gp130 mlLNA (and protein) expression by 
lot,25(OH)2D 3  and  PTH  has  been  reported  in  routine 
MC3T3-E1  cells  and  primary bone  marrow cell  cultures 
(41).  Indeed, it has been proposed that regulation of gp130 
expression by systemic hormones could modulate the sensi- 
tivity of osteoblasts to  cytokines  such  as  IL-11  and  IL-6- 
slL-6Rel (41,  42).  It is not  known if gp130  may be rate- 
limiting for cytokine signal  transduction,  in  the  way that 
low levels of functional IL-6 receptors limit responsiveness 
of osteoblastic  cells  to  IL-6  under  physiological  circum- 
stances (16,  17). Expression ofgpl30 is ubiquitous  (26), but 
it is possible that key target cells, such as bone marrow stro- 
mal cells  might be relatively deficient in gp130 under cer- 
tain conditions. Further studies are required to confirm this 
hypothesis. 
We have reported that OCL formation is induced by at 
least three different mechanisms (32,  33).  The first mecha- 
nism is the PTH-IL-1-PGE2 axis, which is mediated by sig- 
naling involving cAMP.  The  second mechanism is  lo~,25 
(OH)2D3-induced osteoclast formation, which is mediated 
by the vitamin D  receptor but independent of cAMP.  IL-I 
induces  OCL  formation  by  a  mechanism  involving  PG 
production  (39).  The gp130 signal,  activated by cytokines 
such  as  IL-11,  IL-6-slL-6P,  xi,  LIF,  or  OSM,  is  clearly an 
additional  and important pathway of OCL formation. We 
previously  showed  that  anti-IL-6Ro~  antibody  inhibited 
OCL formation by IL-6-slL-6Req but not by IL-1 or lo~,25 
(OH)2D  3 (16).  This indicates that IL-6 is not implicated in 
osteoclastogenesis stimulated by IL-1 or 1eq25(OH)2D3 . In 
the  present study,  neutralizing anti-gp130  antibody,  abol- 
ished osteoclast formation induced by IL-1. Moreover, the 
antibody partially inhibited  the  osteoclastogenic  effects of 
PGE2, PTH, and lo~,25(OH)2D 3. This indicates that gp130 
signals, probably evoked by IL-11, are indispensable for IL-1 
induced OCL formation. This is consistent with the ability 
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teoblasts.  Similarly,  we speculate  that IL-11  contributes,  at 
least in part,  to  OCL  formation  induced  by PGE  2,  PTH, 
and 1ot,25(OH)2D 3. Girasole et al. also reported that a mono- 
clonal anti-IL-11  antibody inhibited PTH-,  lot,25(OH)2D3-, 
IL-I-, or TNFot-mediated OCL formation by between 50- 
100% (15). 
Together,  these results suggest that the gp130 signal is a 
pivotal  cofactor for osteoclast formation.  Targeted  disrup- 
tion  of gpl30  may clarify the  physiological  role  of IL-11 
and  related  cytokines  in  osteoclast  formation  and  skeletal 
development (43). 
Osteotropic  factors appear to act directly on osteoblastic 
cells, which in turn produce  a factor responsible for osteo- 
clast  differentiation  (17,  32).  This  putative  factor may be 
expressed on the cell surface membranes and plays a critical 
role through  a juxtacrine  (cell-to-cell contact)  mechanism. 
In support of this concept, we recently estabhshed that the 
ability of IL-6 to induce  osteoclast differentiation  depends 
on signal transduction  mediated by IL-6 receptors  expressed 
on osteoblastic  cells but not on osteoclast progenitors  (17). 
In view of this evidence, it is likely that IL-11 also induces 
osteoclast  formation by activating  gp130  signals  via  IL-11 
receptors present on osteoblasts. In bone marrow cell cultures, 
which  are  relatively  deficient  in  stromal  cells,  exogenous 
IL-11  is insufficient  to  trigger  osteoclastogenesis  (15),  but 
augments  the  effect  of  lot,25(OH)2D 3,  perhaps  because 
gp130 is upregnlated under these conditions. 
The  demonstration  of IL-11Ret  mRNA  expression  in 
mature  OCLs suggests an important biological function  of 
IL-11 in osteoclasts, perhaps distinct from its role in osteo- 
clast formation.  Ohsaki et al.  (44)  demonstrated functional 
IL-6 receptors  in human  osteoclast-like  cells derived from 
giant cell tumors  of bone.  In these  cells,  IL-6 appeared to 
modulate bone resorbing activity. However, anti-gp130 anti- 
body did  not  influence  pit  resorption  by OCLs  (data  not 
shown).  Macrophage  colony  stimulating  factor  and  IL-1 
appear to  promote  survival  of OCLs  (45),  but  we  found 
that  IL-11  itself did  not  support  OCL  survival  (data  not 
shown).  Further  studies  will  be  required  to  demonstrate 
functional  IL-11 receptors on OCLs and elucidate the role 
of IL-11 in mature osteoclasts. 
In conclusion,  normal osteoblasts are a source of IL-11, 
the production  of which  is induced  by IL-1, TNF,  PGE2, 
PTH,  and  1~x,25(OH)2D 3.  Bone  resorbing  hormones  and 
IL-1  also upregulate gp130 mRNA  in these cells and con- 
sequently cell responsiveness to IL-11 and related cytokines 
may be enhanced.  Both  osteoblasts and mature  OCLs  ex- 
press IL-11Rot mRNA  and thus are potentially able to re- 
spond  to  IL-11.  Signals  mediated  by  gp130  may  be  in- 
volved in  physiological  regulation  of osteoclast  formation 
stimulated by osteotropic factors. Since high local concen- 
trations oflL-1, TNF, and PGs occur in rheumatoid arthri- 
tis synovium  (46),  IL-11  could contribute  to the  excessive 
osteoclastic bone resorption observed in that disease. 
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